Maravai Life Sciences Cuts 25% of Workforce

Dow Jones
2025/08/12

By Natalie Weger

 

Maravai LifeSciences plans to cut 25% of its workforce.

The company's management committed to the workforce reduction on Friday as part of an organizational restructuring, the San Diego-based life sciences company said Monday.

Maravai is expected to incur restructuring and related costs between $8 million and $9 million. These costs consist primarily of employee severance and benefits costs, the majority of which Maravai expects to recognize in the second half of 2025.

The layoffs come as Maravai posts a wider loss and lower revenue in the second quarter.

The company had a loss of $39.6 million, or 27 cents a share, compared with a loss of $9.79 million, or 7 cents a share, last year. Analysts polled by FactSet expected a loss of 17 cents.

Revenue decreased to $47.4 million, compared with $69.4 million last year. The results were aligned with analyst expectations.

 

Write to Natalie Weger at natalie.weger@wsj.com

 

(END) Dow Jones Newswires

August 11, 2025 17:31 ET (21:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10